Paz Ribas

840 total citations
15 papers, 180 citations indexed

About

Paz Ribas is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Paz Ribas has authored 15 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Paz Ribas's work include Multiple Myeloma Research and Treatments (13 papers), Cancer Treatment and Pharmacology (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Paz Ribas is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Cancer Treatment and Pharmacology (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Paz Ribas collaborates with scholars based in Spain, Australia and Greece. Paz Ribas's co-authors include Javier de la Rubia, Juan José Lahuerta, Adrían Alegre, Jesús F. San Miguel, Joan Bladé, Miguel Á. Sanz, Margarita Blanes, José D. González, Carlos Solano and Ángel León and has published in prestigious journals such as Blood, Haematologica and Biology of Blood and Marrow Transplantation.

In The Last Decade

Paz Ribas

14 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paz Ribas Spain 7 152 87 74 18 16 15 180
Dorotea Fantl Argentina 8 132 0.9× 130 1.5× 79 1.1× 7 0.4× 7 0.4× 33 201
M.-P. Pagès France 7 91 0.6× 73 0.8× 31 0.4× 12 0.7× 44 2.8× 14 196
Katarzyna Jamieson United States 9 191 1.3× 131 1.5× 90 1.2× 5 0.3× 6 0.4× 22 267
Da-Cheng Zhou France 7 166 1.1× 235 2.7× 141 1.9× 18 1.0× 17 1.1× 10 327
Tomáš Szotkowski Czechia 7 94 0.6× 42 0.5× 28 0.4× 9 0.5× 5 0.3× 36 137
Clarissa Kooi Netherlands 6 105 0.7× 100 1.1× 42 0.6× 10 0.6× 27 1.7× 7 254
Jennifer Kaivers Germany 7 132 0.9× 39 0.4× 27 0.4× 4 0.2× 10 0.6× 22 172
Fumiaki Sano Japan 6 86 0.6× 77 0.9× 21 0.3× 4 0.2× 5 0.3× 26 153
Isabel Cano Spain 8 80 0.5× 43 0.5× 45 0.6× 10 0.6× 5 0.3× 21 154
Rosane Bittencourt Brazil 10 163 1.1× 102 1.2× 71 1.0× 8 0.4× 9 0.6× 39 238

Countries citing papers authored by Paz Ribas

Since Specialization
Citations

This map shows the geographic impact of Paz Ribas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paz Ribas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paz Ribas more than expected).

Fields of papers citing papers by Paz Ribas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paz Ribas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paz Ribas. The network helps show where Paz Ribas may publish in the future.

Co-authorship network of co-authors of Paz Ribas

This figure shows the co-authorship network connecting the top 25 collaborators of Paz Ribas. A scholar is included among the top collaborators of Paz Ribas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paz Ribas. Paz Ribas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
González‐Calle, Verónica, Paula Rodríguez‐Otero, Anna Sureda, et al.. (2024). Selinexor, daratumumab, bortezomib and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma: results of the phase II, non-randomized, multicenter GEM-SELIBORDARA study. Haematologica. 109(7). 2219–2228. 7 indexed citations
3.
Rodríguez‐Otero, Paula, Verónica González‐Calle, Anna Sureda, et al.. (2021). Selinexor in Combination with Daratumumab-Bortezomib and Dexamethasone for the Treatment of Relapse or Refractory Multiple Myeloma: Initial Results of the Phase 2, Open-Label, Multicenter GEM-Selibordara Study. Blood. 138(Supplement 1). 1677–1677. 8 indexed citations
4.
5.
Ribas, Paz, et al.. (2017). The safety of daratumumab for the treatment of multiple myeloma. Expert Opinion on Drug Safety. 16(6). 753–760. 3 indexed citations
6.
Ribas, Paz, et al.. (2016). Alteraciones de la alineación vertebral. Radiología. 58. 115–127. 1 indexed citations
7.
Mayans, J, Inmaculada Castillo, Manuel Jurado, et al.. (2015). Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy. European Journal Of Haematology. 96(4). 417–424. 1 indexed citations
8.
Rubia, Javier de la, et al.. (2015). Infectious complications in patients with newly diagnosed multiple myeloma: A complication from the past?. Leukemia & lymphoma. 57(2). 258–268. 6 indexed citations
9.
Blanes, Margarita, José D. González, Juan José Lahuerta, et al.. (2014). Bortezomib-based induction therapy followed by intravenous busulfan–melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma. Leukemia & lymphoma. 56(2). 415–419. 6 indexed citations
10.
Blanes, Margarita, Juan José Lahuerta, José D. González, et al.. (2012). Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach. Biology of Blood and Marrow Transplantation. 19(1). 69–74. 49 indexed citations
11.
García‐Sánz, Ramón, Albert Oriol, Javier de la Rubia, et al.. (2012). Analysis of Zoledronic ACID Therapy for Patients with Multiple Myeloma with Asymptomatic Biochemical Relaps.. Blood. 120(21). 2967–2967. 1 indexed citations
12.
13.
Blanes, Margarita, Javier de la Rubia, Juan José Lahuerta, et al.. (2009). Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial. Leukemia & lymphoma. 50(2). 216–222. 17 indexed citations
14.
Carreras, Enric, Laura Rosiñol, María José Terol, et al.. (2007). Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients. Biology of Blood and Marrow Transplantation. 13(12). 1448–1454. 60 indexed citations
15.
Larrea, Luís, et al.. (2004). Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation.. PubMed. 89(10). 1232–7. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorotea Fantl Breakdown of academic impact, for papers by M.-P. Pagès Breakdown of academic impact, for papers by Katarzyna Jamieson Breakdown of academic impact, for papers by Da-Cheng Zhou Breakdown of academic impact, for papers by Tomáš Szotkowski Breakdown of academic impact, for papers by Clarissa Kooi Breakdown of academic impact, for papers by Jennifer Kaivers Breakdown of academic impact, for papers by Fumiaki Sano Breakdown of academic impact, for papers by Isabel Cano Breakdown of academic impact, for papers by Rosane Bittencourt
Rankless by CCL
2026